Analysen von Emmanuel Papadakis
| 17.01.18 | GSK overweight | Barclays Capital | |
| 03.01.18 | Bayer Underweight | Barclays Capital | |
| 21.12.17 | Roche overweight | Barclays Capital | |
| 06.12.17 | Bayer Underweight | Barclays Capital | |
| 17.11.17 | Bayer Underweight | Barclays Capital | |
| 15.11.17 | Sanofi Equal weight | Barclays Capital | |
| 15.11.17 | Novo Nordisk Underweight | Barclays Capital | |
| 07.11.17 | Bayer Underweight | Barclays Capital | |
|
Werbung
|
|||
| 06.11.17 | Bayer Underweight | Barclays Capital | |
| 27.10.17 | GSK Equal weight | Barclays Capital | |
| 25.10.17 | Novartis Underweight | Barclays Capital | |
| 13.09.17 | Roche overweight | Barclays Capital | |
| 13.09.17 | AstraZeneca overweight | Barclays Capital | |
| 10.08.17 | Novo Nordisk Underweight | Barclays Capital | |
| 03.07.17 | AstraZeneca overweight | Barclays Capital | |
| 23.06.17 | Novartis Equal weight | Barclays Capital | |
| 13.06.17 | Roche overweight | Barclays Capital | |
| 02.06.17 | Novartis Underweight | Barclays Capital | |
| 19.05.17 | Roche overweight | Barclays Capital | |
| 19.05.17 | Roche overweight | Barclays Capital | |
| 08.05.17 | Sanofi Underweight | Barclays Capital | |
| 08.03.17 | Novo Nordisk Underweight | Barclays Capital | |
| 08.03.17 | Roche overweight | Barclays Capital | |
| 08.03.17 | Sanofi Underweight | Barclays Capital | |
| 08.03.17 | GSK Equal weight | Barclays Capital | |
| 08.03.17 | AstraZeneca overweight | Barclays Capital | |